American Society of Clinical Oncology Clinical Practice Guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction Article

Visvanathan, K, Chlebowski, RT, Hurley, P et al. (2009). American Society of Clinical Oncology Clinical Practice Guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction . 5(4), 196-199. 10.1200/JOP.0948502

cited authors

  • Visvanathan, K; Chlebowski, RT; Hurley, P; Col, NF; Ropka, M; Collyar, D; Morrow, M; Runowicz, C; Pritchard, KI; Hagerty, K; Arun, B; Garber, J; Vogel, VG; Wade, JL; Brown, P; Cuzick, J; Kramer, BS; Lippman, SM

authors

publication date

  • July 1, 2009

Digital Object Identifier (DOI)

start page

  • 196

end page

  • 199

volume

  • 5

issue

  • 4